TrialInternational journal of colorectal disease2025

The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair-proficient colorectal cancer: preliminary results of a phase 2 study.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.